BRIGHTUNING PEPTIDE AMPOULE

Manufacturer
COSNINE, Inc.
Effective date
2019-12-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:02:17

Label at a glance#

ProductBRIGHTUNING PEPTIDE AMPOULE
Active ingredientNIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

niacinamide

INACTIVE INGREDIENT SECTION

Saccharomyces/Rice Ferment Filtrate
1,2-Hexanediol
Glyceryl Glucoside
Ananas Sativus (Pineapple) Fruit Extract
Butylene Glycol
Glycerin
Betaine
Disodium EDTA
Glyceryl Glucoside
Water
Glycerin
Methylpropanediol
Ammonium Acryloyldimethyltaurate/VP
Copolymer
Ammonium
Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer
Xanthan Gum
Polyglyceryl-6 Stearate
Polyglyceryl-6 Behenate
Caprylic/Capric Triglyceride
Polyglyceryl-3 Distearate
Glyceryl Stearate Citrate
Ethylhexylglycerin
Caprylyl Glycol
Ethylhexyl Palmitate
Glyceryl Stearate
Water
Butylene Glycol
1,2-Hexanediol
Sodium Hyaluronate
Glycerin
Water
Akebia Quinata Extract
1,2-Hexanediol
Water
Pentylene Glycol
Madecassoside
Melia Azadirachta Flower Extract
Ocimum Sanctum Leaf Extract
Melia Azadirachta Leaf Extract
Curcuma Longa (Turmeric) Root Extract
Corallina Officinalis Extract
Water
Eclipta Prostrata Extract
Water
Water
1,2-Hexanediol
Heptasodium Hexacarboxymethyl
Dipeptide-12
Water
1,2-Hexanediol
Pentasodium Tetracarboxymethyl
Acetylhydroxyprolyl Dipeptide-12
Pentasodium Tetracarboxymethyl
Dipeptide-51
Water
1,2-Hexanediol
Dipeptide-1

OTC - PURPOSE SECTION

helps skin whitening

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

apply proper amount to the skin

WARNINGS SECTION

1. Do not use in the following cases(Eczema and scalp wounds)

2.Side Effects

1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor

3.General Precautions

1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately

2)This product is for exeternal use only. Do not use for internal use

4.Storage and handling precautions

1)If possible, avoid direct sunlight and store in cool and area of low humidity

2)In order to maintain the quality of the product and avoid misuse

3)Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73330-0002-12022-01-28C16284748780-1d6a99b39-d2e3-a426-e053-dadaa90af4c2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73330-0002-1BRIGHTUNING PEPTIDE AMPOULE30 mL in 1 BOTTLELIQUID301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73330-0002BRIGHTUNING PEPTIDE AMPOULE (NIACINAMIDE) LIQUID [COSNINE, INC.]1Legacy NDC, 1 package rows20191224_9a6a5e1f-da6d-7a6e-e053-2a95a90aaad0.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73330-000273330-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
GLYCERINPDC6A3C0OXIACT
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9a6a1bcf-31c9-5992-e053-2a95a90a6fb59a6a5e1f-da6d-7a6e-e053-2a95a90aaad02019-12-23WarningsExact identifier
spl id: 9a6a1bcf-31c9-5992-e053-2a95a90a6fb5
spl set id: 9a6a5e1f-da6d-7a6e-e053-2a95a90aaad0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.